Abstract
Bleeding and thrombosis rates are paradoxically increased in chronic kidney disease (CKD), but risk assessment for both is not possible with routine laboratory tests. We aimed to evaluate haemostatic changes in CKD stage 5 patients with modern techniques; using thromboelastometry (TEM), multiple electrode aggregometry (MEA), markers of thrombogenesis, fibrinolysis, and endothelial activation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have